BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time
BioLargo (OTCQX:BLGO), a company focused on sustainable environmental and health technologies, has scheduled its Q1 2025 earnings conference call and webcast for Thursday, May 15, 2025, at 4:30 PM Eastern Time. The event will cover financial results for the quarter ending March 31, 2025, recent company milestones, and include a Q&A session.
Participants can join via webcast or teleconference, with domestic and international dial-in numbers provided. The webcast replay will be available until August 15, 2025, while the teleconference replay will be accessible until May 29, 2025. All presentation materials will be posted on BioLargo's investor relations website.
BioLargo (OTCQX:BLGO), un'azienda focalizzata su tecnologie sostenibili per l'ambiente e la salute, ha programmato la sua conference call e webcast per la presentazione dei risultati del primo trimestre 2025 per giovedì 15 maggio 2025, alle 16:30 ora Eastern. L'evento includerà i risultati finanziari relativi al trimestre terminato il 31 marzo 2025, gli ultimi traguardi aziendali e una sessione di domande e risposte.
I partecipanti potranno collegarsi tramite webcast o teleconferenza, con numeri di accesso nazionali e internazionali disponibili. La registrazione del webcast sarà accessibile fino al 15 agosto 2025, mentre la registrazione della teleconferenza sarà disponibile fino al 29 maggio 2025. Tutti i materiali della presentazione saranno pubblicati sul sito web delle relazioni con gli investitori di BioLargo.
BioLargo (OTCQX:BLGO), una empresa centrada en tecnologías sostenibles para el medio ambiente y la salud, ha programado su conferencia telefónica y webcast de resultados del primer trimestre de 2025 para el jueves 15 de mayo de 2025 a las 4:30 PM hora del Este. El evento incluirá los resultados financieros del trimestre finalizado el 31 de marzo de 2025, los hitos recientes de la empresa y una sesión de preguntas y respuestas.
Los participantes podrán unirse a través de webcast o teleconferencia, con números de acceso nacionales e internacionales disponibles. La repetición del webcast estará disponible hasta el 15 de agosto de 2025, mientras que la repetición de la teleconferencia estará accesible hasta el 29 de mayo de 2025. Todos los materiales de la presentación se publicarán en el sitio web de relaciones con inversionistas de BioLargo.
BioLargo (OTCQX:BLGO)는 지속 가능한 환경 및 건강 기술에 중점을 둔 회사로, 2025년 5월 15일 목요일 동부 표준시 오후 4시 30분에 2025년 1분기 실적 컨퍼런스 콜 및 웹캐스트를 예정하고 있습니다. 이번 행사는 2025년 3월 31일 마감된 분기의 재무 결과, 최근 회사 성과, 그리고 질의응답 시간을 포함합니다.
참석자들은 웹캐스트 또는 전화 회의로 참여할 수 있으며, 국내외 전화 접속 번호가 제공됩니다. 웹캐스트 녹화는 2025년 8월 15일까지, 전화 회의 녹화는 2025년 5월 29일까지 이용 가능합니다. 모든 발표 자료는 BioLargo 투자자 관계 웹사이트에 게시될 예정입니다.
BioLargo (OTCQX:BLGO), une entreprise spécialisée dans les technologies durables pour l'environnement et la santé, a programmé sa conférence téléphonique et webcast pour la publication des résultats du premier trimestre 2025 le jeudi 15 mai 2025 à 16h30 heure de l'Est. L'événement couvrira les résultats financiers du trimestre clos le 31 mars 2025, les récentes étapes importantes de l'entreprise, et comprendra une session de questions-réponses.
Les participants pourront se joindre via webcast ou téléconférence, avec des numéros d'appel nationaux et internationaux fournis. Le replay du webcast sera disponible jusqu'au 15 août 2025, tandis que celui de la téléconférence sera accessible jusqu'au 29 mai 2025. Tous les supports de présentation seront publiés sur le site web des relations investisseurs de BioLargo.
BioLargo (OTCQX:BLGO), ein Unternehmen, das sich auf nachhaltige Umwelt- und Gesundheitstechnologien spezialisiert hat, hat seine Telefonkonferenz und Webcast zur Bekanntgabe der Ergebnisse für das erste Quartal 2025 für Donnerstag, den 15. Mai 2025, um 16:30 Uhr Eastern Time angesetzt. Die Veranstaltung umfasst die Finanzergebnisse für das Quartal bis zum 31. März 2025, aktuelle Unternehmensmeilensteine und eine Fragerunde.
Teilnehmer können über Webcast oder Telefonkonferenz teilnehmen, wobei nationale und internationale Einwahlnummern bereitgestellt werden. Die Aufzeichnung des Webcasts ist bis zum 15. August 2025 verfügbar, die Telefonkonferenz-Aufzeichnung bis zum 29. Mai 2025. Alle Präsentationsmaterialien werden auf der Investor-Relations-Website von BioLargo veröffentlicht.
- None.
- None.
WESTMINSTER, CALIFORNIA / ACCESS Newswire / May 14, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and health challenges, announced it will host an investor webcast and conference call on Thursday, May 15, 2025 at 1:30 pm Pacific / 4:30 pm Eastern. Open to the public, the webcast will be held to review the company's financial results for the three months ended March 31, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/52495
Teleconference Domestic: 877-545-0320
Teleconference International: +1-973-528-0002
Participant Access Code: 359304
To watch or listen to a replay of the webcast or teleconference:
Webcast Replay Expiration: Friday, August 15, 2025
Teleconference Replay Expiration: Thursday, May 29, 2025
Teleconference Replay Domestic: 877-481-4010
Teleconference Replay International: 919-882-2331
Replay Passcode: 52495
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
FAQ
When is BioLargo (BLGO) reporting Q1 2025 earnings?
How can I access BioLargo's Q1 2025 earnings call?
How long will BioLargo's Q1 2025 earnings call replay be available?
What topics will be covered in BioLargo's Q1 2025 earnings call?
